Motley Fool Australia

Anteris Technologies Ltd (ASX: AVR) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $61.75 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 6.57 million
Earnings per share -0.040
Dividend per share N/A
Year To Date Return 121.87%
Earnings Yield N/A
Franking N/A

Anteris Technologies Ltd (ASX: AVR) Latest News

investor looking excited at rising asx 200 share price on laptop

Why the Anteris Technologies (ASX:AVR) share price soared 23% today

More »

Watching ASX share price represented by boy with question mark on forehead looking up

Why the Anteris (ASX:AVR) share price will be on watch today

More »

increase in asx medical software share price represented by doctor making excited hands up gesture

These 2 ASX healthcare shares popped today

More »

soaring hydrix share price represented by doctor riding on top of heart high up in the clouds

Why the Anteris (ASX:AVR) share price is edging higher today

More »

Investor buying shares raining money

Twiggy Forrest backed Invex Therapeutics has now doubled since its IPO

More »

market crash

Why the Admedus share price is sinking again on more big losses

More »

healthcare shares

Insider share buying can’t stop the Starpharma share price sliding again today

More »

laboratory testing medical health

Why the Biotron Limited share price cratered today

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Anteris Technologies Ltd (ASX: AVR)

Formerly known as Admedus Ltd (ASX: AHZ), Anteris Technologies Ltd (ASX: AVR) is a healthcare company specialising in the design and production of heart valve and tissue products.

After having sold the rights to its CardioCel® and VascuCel® patch products in 2019, the company’s main focus today is on its Adapt® BioScaffold products and the development of new heart valve replacement solutions. According to Anteris, the Adapt products are used across more than 135 medical centres globally.

In 2020, the company commenced human trials of its DurAVR™ heart valve.

The Anteris share price has been a highly disappointing performer on the ASX, losing more than 90% of its value over the past five years. The company has executed several capital raisings and has struggled with debt and cash flow issues.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
05 Mar 2021 $9.40 $0.40 4.44% 27,812 $9.40 $9.50 $9.01
04 Mar 2021 $9.00 $0.68 8.17% 12,398 $8.40 $9.00 $8.40
03 Mar 2021 $8.32 $-0.67 -7.45% 17,849 $8.90 $8.90 $8.20
02 Mar 2021 $8.99 $1.39 18.29% 45,649 $7.75 $9.34 $7.71
01 Mar 2021 $7.60 $0.49 6.89% 10,368 $7.23 $7.70 $7.23
26 Feb 2021 $7.11 $-0.11 -1.52% 23,380 $7.22 $7.70 $6.70
25 Feb 2021 $7.22 $0.57 8.57% 40,047 $6.70 $7.60 $6.64
24 Feb 2021 $6.65 $1.13 20.47% 31,003 $5.85 $6.86 $5.66
23 Feb 2021 $5.52 $0.12 2.22% 13,835 $5.41 $5.90 $5.41
22 Feb 2021 $5.40 $0.20 3.85% 33,141 $5.20 $5.80 $5.20
19 Feb 2021 $5.20 $0.20 4.00% 12,905 $5.13 $5.20 $5.00
18 Feb 2021 $5.00 $-0.20 -3.85% 5,672 $5.20 $5.21 $5.00
17 Feb 2021 $5.20 $-0.04 -0.76% 14,769 $5.24 $5.30 $5.20
16 Feb 2021 $5.24 $0.22 4.38% 7,273 $5.18 $5.24 $5.03
15 Feb 2021 $5.02 $0.32 6.81% 39,316 $5.05 $5.25 $5.00
12 Feb 2021 $4.70 $0.01 0.21% 3,057 $4.70 $4.75 $4.65
11 Feb 2021 $4.69 $0.14 3.08% 3,277 $4.56 $4.75 $4.56
10 Feb 2021 $4.55 $0.13 2.94% 6,366 $4.47 $4.59 $4.43
09 Feb 2021 $4.42 $0.02 0.45% 2,326 $4.42 $4.47 $4.41
08 Feb 2021 $4.40 $0.09 2.09% 4,946 $4.40 $4.50 $4.38
05 Feb 2021 $4.31 $-0.34 -7.31% 19,893 $4.65 $4.75 $4.25
04 Feb 2021 $4.65 $-0.16 -3.33% 15,358 $4.80 $4.81 $4.55
03 Feb 2021 $4.81 $0.01 0.21% 3,490 $4.80 $4.90 $4.80
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
10 Dec 2020 John Seaberg Expiry 1 $3,800
10 Dec 2020 Wayne Paterson Expiry 1 $3,800
20 Mar 2020 Wayne Paterson Issued 350 $1,225,000
20 Mar 2020 Stephen (Steve) Denaro Issued 25 $87,500
20 Mar 2020 John Seaberg Issued 60 $210,000


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Stephen (Steve) Denaro Company Secretary,Non-Executive Director Oct 2018
Mr John Seaberg Non-Executive Director,Non-Executive Chairman Oct 2014
Mr Wayne Paterson Managing Director,Chief Executive Officer Feb 2016
Dr Wenyi Gu Non-Executive Director Oct 2018
Matthew McDonnell Chief Financial Officer
Kiran Bhirangi Chief Medical Officer
David St Denis Chief Operating Officer
Martha Engel General Counsel
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Constellation Intl Holdings Limited 730,192 12.35%
HSBC Custody Nominees (Australia) Limited A/C 2 652,219 11.04%
Constellation Immunotherapy Limited 402,093 6.80%
National Nominees Limited <Db A/C> 373,228 6.31%
HSBC Custody Nominees (Australia) Limited Gsco Eca 290,293 4.91%
Star Bright Holding Limited 173,680 2.94%
Merrill Lynch (Australia) Nominees Pty Limited <Mlpro A/C> 169,733 2.87%
J P Morgan Nominees Australia Pty Limited 87,768 1.48%
Citicorp Nominees Pty Limited 84,369 1.43%
Mr Patrick Chew 73,670 1.25%
Dr Abdul Ahad Khan 36,895 0.62%
Mr Daniel Bernard Clough 33,584 0.57%
Through2 Investments Pty Ltd <Through2 Super Fund A/C> 33,000 0.56%
Mr Roger Anthony Pierce 32,673 0.55%
Bulldog Shale Pty Ltd <Bulldog Shale S Fund A/C> 30,000 0.51%
Carron Services Limited 28,572 0.48%
Mr Joseph John Doyle and Mrs Cheryl Anne Doyle 23,527 0.40%
Mr Athanasios Farmakis 23,000 0.39%
Zcsf Nominees Pty Ltd <Zoeller Superfund A/C> 20,505 0.35%
Mr Dale Anthony Reed 20,000 0.34%
Appwam Pty Ltd 20,000 0.34%
Mrs Janet Louise Bowtell and Mr Gary Owen Bowtell <Bowtell Super Fund A/C> 20,000 0.34%
Show more